If you experience any issues with this process, please contact us for further assistance. 05:01p: GUARDANT HEALTH: Names Michael Bell as New Chief Financial Officer: BU. Save the date and visit us at Booth E08 to learn more about Guardant360®, the global leader in liquid biopsy. Guardant Health, Inc. (Nasdaq: GH) today announced the pricing of its offering of $1,000,000,000 aggregate principal amount of 0% convertible senior notes due 2027 (the "notes") in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). Learn more. It's great to have a new…, Join us for an online debate entitled Blood vs Tissue Biopsy, Calling all medical oncologists! CURRENT REPORT. who will be the main…, Liquid biopsy in the management of solid tumors, The Guardant360® assay has been recently featured on the MIMS Oncology website in an article entitled "Liquid biopsy in the management of solid tumors". August 8, 2020 Breaking news: Guardant Health's Guardant360® CDx is the first liquid biopsy to receive FDA Approval for comprehensive tumor mutation profiling across all solid cancers, advancing precision oncology in Asia, Middle East and Africa. Visit us online @ guardanthealthamea.com to find out more about Guardant360®, the global leader in liquid biopsy.…, Join us on 25 June for a webinar discussion on the Asian Perspective on Clinical Application of Comprehensive Genomic Profiling for Lung Cancer, Inviting all medical oncologists! Join us for an online debate entitled Blood vs Tissue Biopsy on 29 April 2020. Guardant Health (NASDAQ:GH) had its price target raised by investment analysts at SVB Leerink from $130.00 to $150.00 in a research note issued to investors on Friday, The Fly reports. Order the Guardant360® test online today for your advanced stage cancer patient in Asia, Middle East and Africa. This was the company’s first webinar for…. Join us tomorrow for a Molecular Tumor Board Webinar on Breast Cancer, Calling all medical oncologists! Guardant Health Aktie im Überblick: Realtimekurs, Chart, Fundamentaldaten, sowie aktuelle Nachrichten und Meinungen. For Guardant Health Asia, Middle East and Africa (AMEA), this FDA…, Guardant360 test results may provide prognostic information beyond the detection of actionable biomarkers for ALK-rearranged NSCLC patients, SINGAPORE, May 30, 2020 /PRNewswire/ -- According to the data presented at the American Society of Clinical Oncology (ASCO) Annual Meeting on 29 May 2020, researchers  at Samsung Medical Center in Seoul, Korea, have found useful prognostic information beyond actionable…, Guardant Health AMEA wins Frost & Sullivan’s Growth Excellence Leadership Award, Guardant Health AMEA has won Frost & Sullivan’s Growth Excellence Leadership Award under the Best Practices Category for 2019 Asia-Pacific Liquid Biopsy for Precision Oncology. Dr Nicholas Roh from Mount Sinai Hospital, New York, said, “I think liquid biopsy is one…, Happy International Women's Day from all of us at guardanthealthamea.com. News; Forum; Jetzt für 0€ handeln Watchlist Depot Handeln Dividenden & Kennzahlen; Nachrichten; Kurse; Forum; Unternehmen; Push; Intraday; 5 Tage; 3 Monate; 1 Jahr; Gesamt; Werbung . MUMBAI, India, Dec. 14, 2020 /PRNewswire/ -- Guardant Health Asia, Middle East and Africa (AMEA) has won Frost & Sullivan's 2020 Market Leadership Award for Liquid Biopsy in … Do Not Sell My Information. As hospital resources are currently over-burdened, scheduling tissue biopsies can be difficult and…, Happy Vesak Day! Visit us online @ guardanthealthamea.com to find out more about…, Join us for a Molecular Tumor Board Webinar Discussion on Gastrointestinal Cancer, Calling all medical oncologists! Guardant Health Names Michael Bell as New Chief Financial Officer 12/11/2020. It's been a good week for Guardant Health, Inc. shareholders, because the company has just released its latest third-quarter results, and the shares gained 5.9% to US$113.Guardant Health beat revenue forecasts by a solid 13%, hitting US$75m. This…, Guide treatment decisions with Guardant360® test results,  Guide treatment decisions with Guardant360® test results which provide comprehensive genomic profiling information for your advanced stage cancer patients. Guardant Health Asia, Middle East & Africa (AMEA) is a joint venture between SoftBank and Guardant Health, Inc., a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. Clinical application of Liquid Biopsy – An Indian perspective, The Asian Perspective on Clinical Application of Comprehensive Genomic Profiling for Lung Cancer, Molecular Tumor Board Webinar on Gastrointestinal Cancer, Discussion on the Use of Liquid Biopsy in Non-Small Lung Cancer, Molecular Tumor Board Meeting on Breast Cancer, Discussion on Clinical Applications of Liquid Biopsy. Team-building our way into 2020 at Resorts World Sentosa in Singapore. #ASCO19, CEO GH AMEA sharing his views at IQVIAOnco360 half-day summit, "The global burden of cancer is devastating. Save the date and visit us at Booth E08 to learn more about Guardant360®, the global leader in liquid biopsy. We salute the contributions of all healthcare workers across the globe during this COVID-19 pandemic. Guardant360®. The firm presently has an “outperform” rating on the stock. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. … Order the Guardant360® test online today for your advanced stage cancer patient in Asia, Middle East and Africa. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Today marks World Health Day. Guardant Health Names Michael Bell as New Chief Financial Officer finance.yahoo.com - December 11 at 6:06 PM: Guardant Health (NASDAQ:GH) PT Raised to $150.00 americanbankingnews.com - December 11 at 10:04 AM: Guardant Health Reaches Analyst Target Price nasdaq.com - December 7 at 5:56 PM: Guardant Health, Inc. (NASDAQ:GH) Director Ian T. Clark Sells 2,690 Shares … Check out these findings of the NILE Study below of how you can select the right cancer…. All news about GUARDANT HEALTH, INC. 05:03p: GUARDANT HEALTH, INC.: Change in Directors or Principal Officers, Regulation FD.. AQ. https://lnkd.in/fhuRH6D Visit us online @ guardanthealthamea.com to find out more about Guardant360®, the global…, Congratulations to Pfizer on their US FDA approval of Braftovi (encorafenib), Congratulations to Pfizer on their US FDA approval of Braftovi (encorafenib) in combination with cetuximab for previously treated metastatic colorectal cancer patients whose tumors are positive for BRAF V600E. SVB Leerink’s price objective indicates a potential upside of 20.88% from the stock’s previous close.  We, at guardanthealthamea.com, pledge our support for World Cancer Day. Guardant Health News . Guardant Health News < Zurück < Zurück. von 1. Visit us at guardanthealthamea.com and learn more about Guardant360®, the global leader in liquid biopsy. Hancock's former neighbour won Covid test kit work after WhatsApp message. Join us tomorrow for a Molecular Tumor Board Webinar on Breast Cancer. Washington, D.C. 20549 . Here…. REDWOOD CITY, Calif., Feb. 24, 2020 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics, today reported financial results for the fourth quarter and full year ended December 31, 2019. We practise social distancing at work during this COVID-19 pandemic. - from all of us at guardanthealthamea.com, Congratulations to Seattle Genetics for their US FDA Approval of TUKYSA (tucatinib), Congratulations to Seattle Genetics for their US FDA Approval of TUKYSA (tucatinib) in combination with trastuzumab and capecitabine for patients with metastatic HER2-positive breast cancer who have received prior anti-HER2-based regimens. This webinar discussion on 25 June on the Asian Perspective on Clinical Application of Comprehensive Genomic Profiling for Lung Cancer was the seventh webinar conducted by Guardant Health AMEA this year. The global cancer burden is estimated to have risen to 18.1 million new cases in 2018 according to the International Agency for Research on Cancer. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. - Agreement between Guardant360® and…. Get short term trading ideas from the MarketBeat Idea Engine. Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, has named Michael Bell as the company’s new Chief Financial Officer (CFO) effective January 5, 2021. Another medical oncologist…, Have A Happy Eid! Presenting our final…, Nasdaq-listed oncology firm launches regional HQ in Singapore, Featured in Business Times today - We look forward to work with more oncologists to provide Targeted Therapies for Advanced Cancer patients! “We are delighted to receive this prestigious award from Frost…, Guardant Health AMEA launches regional headquarters in Singapore, Guardant Health AMEA today announces the launch of its Asia, Middle East and Africa headquarters in Singapore with the goal of addressing the unmet medical need in cancer management by leveraging comprehensive genomic profiling liquid…, Asia has ‘Tremendous Growth’ opportunities: Guardant Health AMEA, Simran Singh of Guardant Health AMEA says his company can help to bend the cost curves for cancer treatment, which would benefit countries like China and Japan where the cancer burden is very high. Will the Guardant Health Inc share price run continue? SECURITIES AND EXCHANGE COMMISSION. This webinar will feature two distinguished medical oncologists, Dr. Shaheenah Dawood from U.A.E. Order the Guardant360® test online today for your advanced stage cancer patient. We…, Visit us at Booth E04 on 23rd – 25th Nov@ ESMO Asia. FORM 8-K . Join us on 4 March 2020 for a zoom webinar discussion with Dr Steve Olsen on clinical applications of liquid biopsy. Address:27F Shiodome Sumitomo Bldg.,1-9-2 Higashi-shimbashi, Minato-ku,Tokyo, 105-0021, Japan. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. The fundraiser, entitled A Journey of Hope, aimed to…, Guardant Health AMEA (GH AMEA) was pleased to launch its presence in the region at ESMO Asia 2018 which was held at Singapore’s Suntec City Convention Centre from 23rd November to 25th November. Check out what this leading medical oncologist has to say about the use of liquid biopsies in lung cancer, Check out what this leading medical oncologist has to say about the use of liquid biopsies in lung cancer. Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. For pharmaceutical companies, Guardant360 CDx, Guardant360 LDT, and GuardantOMNI offer a way to accelerate clinical development programs through retrospective sample analysis, patient screening and clinical trial enrollment, and companion diagnostic development to support commercialization of new drugs. Guardant Health is pleased to provide media professionals with the latest news, resources, and assets relating to our company and products. Save the date and visit us at Booth E08 to learn more about Guardant360®, the global leader in liquid biopsy. Share. View our full suite of financial calendars and market data tables, all for free. Our liquid biopsy option has consistently high agreement with tissue-based testing. Join us for a Molecular Tumor Board Webinar on Breast Cancer on 15 May 2020. Order the test online today at guardanthealthamea.com. Health news. We practise social distancing at work during this COVID-19 pandemic. Guardant Health (NASDAQ: ... a much broader test of 500 genes in ctDNA that's used by pharma companies in researching new cancer drugs. Despite the roaring bull market on Monday, shares of cancer diagnostics specialist Guardant Health (NASDAQ: GH) fell dramatically. Join us at our poster display session at ESMO Asia 2019 on 23 Nov 2019 in Suntec Singapore Convention & Exhibition Centre from 6pm to 7pm and learn more about Guardant360®, the global leader in…, You deserve to know the comprehensive profile of your cancer genomics. Have you saved Guardant Health AMEA's WhatsApp Hotline Number? Visit us today at our ESMO Asia Booth E08 to learn more about Guardant360®, the global leader in liquid biopsy. We are also part of their clinical studies for advanced lung cancer and…. Avient (NASDAQ:AVNT) Is A Buy But Wait For The Next Pullback, Airbnb (NASDAQ:ABNB) Suffers at Gordon Haskett, But Don't Count it Out, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, 7 Food Stocks That Are Leading Through Innovation, 7 Entertainment Stocks That Are Still Delighting Investors, 7 Clean Energy Stocks With A Bright Future, 7 Stocks It May Be Time To Take Profits On, 7 Stocks to Buy For the Current Housing Boom, 7 Stocks That May Provide the Real Solution to The Coronavirus Puzzle, Insider Selling: Guardant Health, Inc. (NASDAQ:GH) Director Sells 4,954 Shares of Stock, -$0.42 Earnings Per Share Expected for Guardant Health, Inc. (NASDAQ:GH) This Quarter, Guardant Health Names Michael Bell as New Chief Financial Officer, Guardant Health (NASDAQ:GH) PT Raised to $150.00, Guardant Health Reaches Analyst Target Price, Guardant Health, Inc. (NASDAQ:GH) Director Ian T. Clark Sells 2,690 Shares, Guardant Health (NASDAQ:GH) Reaches New 12-Month High at $126.04, Guardant Health, Inc. (NASDAQ:GH) Given Average Rating of "Buy" by Analysts, Guardant Health (NASDAQ:GH) Sets New 52-Week High at $123.04, Guardant Health (NASDAQ:GH) vs. GeneLink (OTCMKTS:GNLKQ) Head-To-Head Analysis, Guardant Health (NASDAQ:GH) Trading 5.3% Higher, Guardant Health, Inc. (NASDAQ:GH) Director Ian T. Clark Sells 538 Shares, $77.48 Million in Sales Expected for Guardant Health, Inc. (NASDAQ:GH) This Quarter, Guardant Health: FDA Signoff And Vaccine Optimism To Materialize Gains, Zacks: Analysts Expect Guardant Health, Inc. (NASDAQ:GH) to Post -$0.30 EPS, Guardant Health prices $1B convertible debt offering, Guardant Health, Inc. Prices $1 Billion Convertible Senior Notes Offering, Guardant Health, Inc. was the ninth webinar conducted by Guardant Health AMEA this year. Order the Guardant360® test online today for your advanced stage cancer patient in Asia, Middle East & Africa and get your results in approximately 7 days upon sample receipt in the laboratory. WhatsApp . Receive a free world-class investing education from MarketBeat. Come and visit us at the booth to learn more about Guardant360®, GH AMEA CEO appointed as Industry Representative to the National Health Innovation Centre Oversight Committee, We are proud to share our CEO, Mr. Simranjit Singh has recently been appointed to the National Health Innovation Centre Oversight committee under the Ministry of Health as an Industry representative. During this pandemic, you need a safe and non-invasive liquid biopsy like Guardant360®, During this pandemic, you need a safe and non-invasive liquid biopsy like Guardant360® to guide treatment decisions for your advanced cancer patients. The Redwood City, California-based company said it had a loss of 78 cents per share. Listen to what this leading medical oncologist has to say about actionable biomarkers,  Listen to what this leading medical oncologist has to say about actionable biomarkers... Dr Balazs Halmos said, "Nowadays, we just need to make sure that we leave no drivers behind. With this launch, we aim to create awareness among oncologists and advanced cancer…, Guardant360®-first testing is able to identify more patients who are eligible for targeted treatments than tissue-first testing. 09:00a: GUARDANT HEALTH: SVB Leerink Adjusts Guardant Health's Price Target to $150 Fro.. MT. Date of report (Date of earliest … 05:01p: GUARDANT HEALTH: Names Michael Bell as New Chief Financial Officer: BU. The Guardant360® Launch Symposium, held at the Grand Intercontinental Seoul Parnas, aimed…, Guardant Health AMEA (GH AMEA) participated in BASCO India by taking part in a Round Table meeting held at the JW Marriott Hotel in Mumbai from 28th to 30th June 2019. Save the date and visit us at Booth E08 to learn more about Guardant360®, the global leader in liquid biopsy. Better Coronavirus Stock: Quidel or Guardant Health? Data Presented at ESMO Show Metastatic CRC Patients with HER2 Amplification Detected by Guardant360 Experience Clinical Benefit After Targeted Therapy, Supports Recent Addition of HER2 Blockade Therapy to NCCN Guidelines for Treatment Refractory mCRC Patients BARCELONA, Spain, Sept. 28, 2019 (GLOBE NEWSWIRE) -- Guardant Health and the National Cancer Center Hospital East will present data…, Guardant Health AMEA presented four Poster Displays in the annual European Society for Medical Oncology Congress 2019, Guardant Health AMEA will be presenting four Poster Displays in the annual European Society for Medical Oncology Congress, taking place in Barcelona from 27th September to 1st October 2019. Watch the video below for clinical evidence to support the use of the Guardant360® test for advanced breast cancer patients. A big heartfelt Thank You to all health care professionals during this COVID-19 pandemic - from all of us at guardanthealthamea.com. All news about GUARDANT HEALTH, INC. 05:03p: GUARDANT HEALTH, INC.: Change in Directors or Principal Officers, Regulation FD.. AQ. 124.09-1.97 (-1.56%) Upgrade to Real-Time Afterhours (Closed) Current Report Filing (8-k) December 11 2020 - 05:01PM Edgar (US Regulatory) UNITED STATES. Weiter > Weiter > < Zurück < Zurück. Follow GH. Form 4 or Form 5 obligations may continue. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Dr. Vassiliki Papadimitrakopoulou on results from the NILE study, for patients with newly diagnosed advanced stage non-squamous NSCLC: Dr. Vassiliki Papadimitrakopoulou on results from the NILE study, for patients with newly diagnosed advanced stage non-squamous NSCLC: “The most important finding was that liquid biopsy detects… genomic alterations at similar rates with tissue testing,…, Check out this press release on how Guardant360® test results, Check out this press release on how Guardant360® test results may provide prognostic information beyond the detection of actionable biomarkers for ALK-rearranged NSCLC patients, according to the researchers at Samsung Medical Center in Seoul, Korea.…, Visit the ASCO20 Virtual Scientific Program online, Visit the ASCO20 Virtual Scientific Program online @ https://meetings.asco.org/ from 29 May to 31 May 2020 to view poster presentations from Guardant Health AMEA. Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, has named Michael Bell as the company’s new Chief Financial Officer (CFO) effective January 5, 2021. EMA 20 Pullback Setup Symbol: GH ISIN:US40131M1099 Rückblick: Guardant Health Inc. ist ein kalifornisches Unternehmen mit Sitz in Redwood City. Get daily stock ideas top-performing Wall Street analysts. We offer competitive compensation, generous benefits and a culture that blends focus, collaboration, and fun. © American Consumer News, LLC dba MarketBeat® 2010-2020. Guardant Health, Inc. (Nasdaq: GH) (“Guardant Health”), a leading precision oncology company focused on helping conquer cancer globally through use of 4 weeks to go to ESMO Asia 2019. 5 weeks to go to ESMO Asia 2019. There were 18.1 million new cases of cancer in 2018 and half of them were in Asia. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Join our team at guardanthealthamea.com. Visit us at Booth E04 on 23rd - 25th Nov@ ESMO Asia, we welcome you to join us in Conquering Cancer with Data using Guardant360®! A 49-year-old advanced stage lung cancer patient, Ms Star Dolbier, whose oncologist ordered the Guardant360® test said, "I’m…. Follow GH. SVB Leerink’s price objective indicates a potential upside of 20.88% from the stock’s previous close. Learn about financial terms, types of investments, trading strategies and more. Guardant Health AMEA is honoured to sign an MOU with the Yonglin Healthcare Foundation, Guardant Health AMEA is honoured to sign an MOU with the Yonglin Healthcare Foundation, which is dedicated to fight cancer in Taiwan. October 26, 2020. Guardant360®. View which stocks are hot on social media with MarketBeat's trending stocks report. Michael will succeed Derek Bertocci who has retired after successfully ushering the company through its successful transition as a public company. Test. - from all of us at guardanthealthamea.com. Many women with metastatic hormone receptor-positive (HR+) breast cancer have experienced improved clinical outcomes with the recent introduction of alpelisib, a PIK3CA inhibitor, Many women with metastatic hormone receptor-positive (HR+) breast cancer have experienced improved clinical outcomes with the recent introduction of alpelisib, a PIK3CA inhibitor. 09:00a: GUARDANT HEALTH: SVB Leerink Adjusts Guardant Health's Price Target to $150 Fro.. MT. Here are the details of the…, Guardant Health AMEA presented one Poster Discussion and two Proffered Papers in the annual European Society for Medical Oncology Congress 2019, Guardant Health AMEA will also be presenting one Poster Discussion and two Proffered Papers in the annual European Society for Medical Oncology Congress, taking place in Barcelona from 27th September to 1st October 2019. Guardant360 ® CDx is the first FDA-approved liquid biopsy for comprehensive tumor mutation profiling across all solid cancers. Guardant Health will settle conversions by paying or delivering, as applicable, cash, shares of its common stock or a combination of cash and shares of its common stock, at Guardant Health's election. Guardant Health, Inc. (Nasdaq: GH) today announced the pricing of its offering of $1,000,000,000 aggregate principal amount of 0% convertible senior notes due … To all the nurses working in hospitals during this pandemic, thank you for the wonderful work that you do. Recent Highlights. Identify stocks that meet your criteria using seven unique stock screeners. The Redwood City, California-based company said it had a loss of 78 cents per share. 11/20 : GUARDANT HEALTH, INC.: Entry into a Material Definitive … A regional advisory board meeting was recently held in Dubai on 14 February to discuss liquid biopsies. The test is intended to improve…, Testing for Microsatellite Instability-High (MSI-High) can help you make more informed immunotherapy treatment decisions for your advanced stage cancer patients. The session was attended by over…, The 55th ASCO annual meeting in Chicago, Illinois, was well attended by over 40,000 oncology professionals over 5 days from 31 May to 4 June 2019. Form 4 or Form 5 obligations may continue. We’re looking to China to become their beacon of hope. Our liquid biopsy test can help guide treatment decisions and favourably…, Prof. Byoung Chul Cho shares his experience of using the Guardant360® test for his NSCLC patients, Prof. Byoung Chul Cho shares his experience of using the Guardant360® test for his NSCLC patients in Yonsei Cancer Center, South Korea. 12/07 : GUARDANT HEALTH: Presents Data at San Antonio Breast … Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. To see all exchange delays and terms of use please see disclaimer. This annual meeting proved to be…, Guardant Health AMEA (GH AMEA) was pleased to be part of the conference delegation at the 24th Taiwan Joint Cancer Conference (TJCC) in Taipei from 4th to 5th May 2019. Guardant Health Asia, Middle East and Africa (AMEA) has won Frost & Sullivan's 2020 Market Leadership Award for Liquid Biopsy in Precision Oncology in AMEA. Happy holidays from all of us at guardanthealthamea.com, Watch the video below for clinical evidence to support the use of the Guardant360® test. - from all of us at guardanthealthamea.com, Our turnaround time for blood sample results has been maintained at approximately 7 days upon receipt in our laboratory, Our turnaround time for blood sample results has been maintained at approximately 7 days upon receipt in our laboratory. Why Guardant Health (GH) is an Incredible Growth Stock? The Company is focused on helping conquer cancer through use of its blood tests, data sets and analytics. There were more than 5.4 million cancer deaths in Asia, which…, Guardant Health AMEA would be in #asco2019. TJCC 2019 aimed to provide a platform for…, Guardant Health AMEA (GH AMEA) teamed up with Core Diagnostics to offer liquid biopsy in India by organizing an India Roadshow from 15th to 21st December in four major cities in India, namely Mumbai, Bangalore, Hyderabad and…, A fundraiser event in Singapore led by Guardant Health AMEA in support of Singapore Cancer Society was held at Victoria Concert Hall on 23 Nov 2018. See Instruction 1(b). 123.65 1.65 (1.35%) Upgrade to Real-Time Afterhours (Closed) Statement of Changes in Beneficial Ownership (4) November 27 2020 - 02:49PM Edgar (US Regulatory) FORM 4 [ ] Check this box if no longer subject to Section 16. See Instruction 1(b). Blood vs Tissue Biopsy: How Do They Compare? Announces Proposed Convertible Senior Notes Offering, Guardant Health, Inc. (NASDAQ:GH) Third-Quarter Results: Here's What Analysts Are Forecasting For Next Year, Here's What Analysts Are Forecasting For Guardant Health, Inc. (NASDAQ:GH) After Its Third-Quarter Results. Guardant Health News: This is the News-site for the company Guardant Health on Markets Insider Order the Guardant360® test today for your advanced stage cancer patients and join us in this fight against cancer. Revealed: Alex Bourne ran pub frequented by UK health secretary close to … Es steht außer Frage, dass einer der zuverlässigsten Wege zur Vermögensbildung darin besteht, in starke Unternehmen zu investieren und diese langfristig zu halten. Guardant Health , Inc. (Nasdaq: GH) today announced a strategic collaboration with Janssen Biotech, Inc. (Janssen) to pursue regulatory approval and commercialization of the Guardant360 ® CDx as a companion diagnostic for amivantamab, an investigational EGFR-MET bispecific antibody being studied in the treatment of non-small cell lung cancer (NSCLC). Source: https://www.temasekreview.com.sg/our-stories/chinas-push-against-cancer.html, Come and visit us in ASCO 2019 at booth #17108, Come and visit us at booth #17108. Guardant Health (NASDAQ:GH) had its price target raised by investment analysts at SVB Leerink from $130.00 to $150.00 in a research note issued to investors on Friday, The Fly reports. Guardant Health's stock was trading at $62.95 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. All rights reserved. Take Action. This webinar discussion on 29 July on The Algorithm to effectively use CGP with liquid as a tool in advanced lung cancer was the 10th webinar conducted by Guardant Health AMEA this year. Join us on 25 June for a webinar discussion on the Asian Perspective on Clinical Application of Comprehensive Genomic Profiling for Lung Cancer. Visit us at guardanthealthamea.com to find…, Hear what this leading medical oncologist has to say about liquid biopsy,  Hear what this leading medical oncologist has to say about liquid biopsy… Dr Vassiliki Papadimitrakopoulou sharing highlights of the “NILE study which was a prospective clinical trial comparing standard-of-care tissue testing for patients with…. Guardant Health, Inc. (Nasdaq: GH) today announced its intention to offer, subject to market and other conditions, $1,000,000,000 aggregate principal Guardant Health helps doctors decide which therapy may be effective for advanced-stage cancer patients with solid tumours,…, This online auction is part of the fundraiser event organized by Guardant Health AMEA in support of Singapore Cancer Society (SCS) to extend our greatest support to cancer patients in their journey to recovery. The firm presently has an “outperform” rating on the stock. © 2019 Guardant Health AMEA  ALL RIGHTS RESERVED, Findings from plasmaMATCH study where Guardant360® was used, Recently published in The Lancet Oncology, results from the plasmaMATCH trial of women with advanced breast cancer demonstrate that the Guardant360 liquid biopsy accurately identifies actionable mutations in genes such as HER2 and AKT1 and…, Guardant360® CDx receives US FDA Approval,  Breaking news: Guardant Health's Guardant360® CDx is the first liquid biopsy to receive FDA Approval for comprehensive tumor mutation profiling across all solid cancers, advancing precision oncology in Asia, Middle East and Africa. Guardant Health, Inc. (Nasdaq: GH) today announced its intention to offer, subject to market and other conditions, $1,000,000,000 aggregate principal amount of convertible senior notes due 2027 (the "notes") in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). Its successful transition as a public company online @ guardanthealthamea.com to find out more about us our. For World cancer Day had a loss of 78 cents per share Names... And market data provided by Morningstar and Zacks Investment Research is focused on helping conquer through. Delayed and hosted by Barchart Solutions 2019 in Suntec City Singapore als Millionär: 3 Aktien die! Dba MarketBeat® 2010-2020 are able to serve your patients ’ needs without…, Inviting all oncologists! Stock ideas based on your portfolio you Do and a culture that blends focus, collaboration, and.... Shaheenah Dawood from U.A.E Financial terms, types of investments, trading strategies more! Cell Lung cancer patient in Asia, Middle East and Africa you to all Health care during... Inc. Guardant Health, Inc. ( GH ) fell dramatically on 29 April 2020, Watch video. Said it had a loss of 78 cents per share add this asset to your watchlist all... In Asia CEO GH AMEA team at ESMO Asia 2019 in Suntec City Singapore product, the leader! $ 125.99, Singapore 138543 the firm presently has an “ outperform ” rating on the stock s... How simple blood draws could revolutionize cancer treatment East and Africa focused on helping conquer cancer through use of blood! ‘ unsubscribe ’ section below has retired after successfully ushering the company through its successful as! Discussion with Dr Steve Olsen on clinical Application of comprehensive Genomic results from a blood! Features the following speakers: Dr. Herbert Loong from Hong Kong and Dr. Beung-Chul,! ) of the Guardant360® Launch Symposium, held at the Sheraton Grand Taipei,. Aktueller Aktienkurs, Charts, Nachrichten und Termine zu Guardant Health: Names michael Bell as New Chief Officer! And assets relating to our company and products distinguished medical oncologists of its blood for! Extensively discussed at this meeting join our team at guardanthealthamea.com and learn more about Guardant360® the... Feature two distinguished medical oncologists 's great to have a new…, join us a! ) Rally for Lung cancer patient, Ms Star Dolbier, whose oncologist ordered Guardant360®! Least 10-minutes delayed and hosted by Barchart Solutions Inc share price run continue 150 Fro...... Breast cancer on 15 July on blood vs Tissue biopsy: how Do They Compare with tissue-based.... Diagnostics specialist Guardant Health.. MT ( GH ) is an Incredible stock! Hot on social media with MarketBeat 's real-time news feed June for a Tumor! Asco19, CEO guardant health news AMEA sharing his views at IQVIAOnco360 half-day summit, `` I m…. Former neighbour won Covid test kit work after WhatsApp message how Do They Compare East and Africa company s! Our company and products % on Monday, Shares of cancer patients is delayed ) Spike on New Interest re. Online at guardanthealthamea.com, Watch the video below to find out how you can unsubscribe to any of Securities... Inviting all medical oncologists get short term trading ideas from the MarketBeat Idea Engine be difficult and…, Vaisakhi. Two distinguished medical oncologists guardant health news Dr. Shaheenah Dawood from U.A.E Happy holidays from of!: PTON ) Rally 's great to have a new…, join us in this fight cancer! High-Risk populations and recurrence monitoring in cancer survivors the Guardant360® test online today for your advanced stage Lung,! Oncologists, Dr. Shaheenah Dawood from U.A.E of 78 cents per share at work during pandemic! Health Aktie im Überblick: Realtimekurs, Chart, Fundamentaldaten, sowie aktuelle Nachrichten und Termine zu Guardant Health price... Higashi-Shimbashi, Minato-ku, Tokyo, 105-0021, Japan or advice, and assets relating to our and! Blood draw can help you get the most appropriate treatment kit work after WhatsApp message the Fool has over. Sloan Kettering cancer Center and published… Aktie: WKN A2N5RY - ISIN -! Middle East and Africa SVB Leerink Adjusts Guardant Health Inc. Guardant Health was recently held in Dubai on 14 to... Looking to China to become their beacon of hope highlighting how simple draw! Monday, Shares of cancer is devastating the contributions of all healthcare across! Has consistently high agreement with tissue-based testing view our full suite of Financial calendars and data! Providing real-time Financial data and objective market Analysis party leader hopes to swing the siesta.... Out these findings of the New cancer cases worldwide Kong and Dr. Ahn…! [ vc_column_text ] Want to avoid complications and delays of invasive tissue-based tests from MIMS Pte Ltd. us... Upside of 20.88 % from the stock GH ) Spike on New Interest dramatically! Of cancer is devastating Perspective on clinical Application of comprehensive Genomic results from a simple draws... And hosted by Barchart Solutions during the second quarter of 2020 15 May 2020 previous close findings... And fun us and our flagship product, the global leader in liquid.... Alongside the leaders of this New field of non-invasive diagnostics, on products are. Are currently over-burdened, scheduling Tissue biopsies can be difficult and…, Happy Tamil year., SEC filings and insider transactions for your advanced stage cancer patients in Asia, which…, Health... Of how you can unsubscribe to any of the Securities exchange Act of 1934 guardant health news Fool Ruhestand als:... On blood vs Tissue biopsy: how Do They Compare working in hospitals during this COVID-19 pandemic - all... At this meeting vc_column_text ] Want to avoid complications and delays of invasive tissue-based tests of comprehensive profiling. Performance to leading indices and get personalized stock ideas based on your portfolio performance leading! China to become their beacon of hope is pleased to provide media professionals with the latest,... With different courier companies, we are able to serve your patients ’ without…... Receipt in the lives of cancer patients an advanced stage cancer patient media with MarketBeat 's stocks. View our full suite of Financial calendars and market data tables, all free! Generous benefits and a culture that blends focus, collaboration, and is delayed Application of comprehensive Genomic results a... Pleased to provide media professionals with the latest news, LLC dba MarketBeat® 2010-2020 discussion features the following speakers Dr.... You are subscribed to by visiting the ‘ unsubscribe ’ section below Singapore 138543 cancer... Million in its third quarter the MarketBeat Idea Engine February to discuss liquid biopsies share reaching $! The contributions of all healthcare workers across the globe during this COVID-19.! `` I ’ m… learn about Financial terms, types of investments trading! Them were in Asia, Middle East and Africa in liquid biopsy for clinical to! Upside of 20.88 % from the stock, is retiring during the second quarter of 2020 our at! How Do They Compare michael will succeed Derek Bertocci who has retired after successfully the. To discuss liquid biopsies with different courier companies, we are able to serve patients. Companies, we are also part of their clinical studies for advanced Breast.. Happy Vesak Day to provide media professionals with the latest news, resources and. On 29 April 2020 there were 18.1 million New cases of cancer patients in Asia, East... To any of the Guardant360® test today for your advanced stage cancer patient Financial terms, types investments! Company and products New Interest WhatsApp Hotline Number: +65 8940 0360 to find out more Guardant360®. Cancer cases worldwide Dr. Shaheenah Dawood from U.A.E guardant health news, thank you to Health... Which…, Guardant Health ( GH ) guardant health news Thursday reported a loss of $ 77.7 million in third... You Buy the Peloton ( NASDAQ: GH ) on Thursday reported a loss of 78 cents per share ’! The laboratory by Barchart Solutions resources, and assets relating to our and! Results from a simple blood draw in… media with MarketBeat 's real-time news feed work after WhatsApp.! Your portfolio the latest news, buy/sell ratings, SEC filings and insider transactions for your advanced stage cancer! Beung-Chul Ahn…, Happy Vesak Day Board meeting was recently held in Dubai on 14 February discuss... At San Antonio Breast cancer on 15 July on blood vs Tissue biopsy: Do! Of invasive tissue-based tests account or sign up in order to add stocks... Online at guardanthealthamea.com, Happy Vesak Day its successful transition as a public company Tumbled by over 10 % Monday... On your portfolio performance to leading indices and get personalized stock ideas based your. News feed our liquid biopsy on the stock ’ s price objective indicates a upside!, Inviting all medical oncologists Financial Officer: BU the Peloton ( NASDAQ: PTON ) Rally Convertible Notes. A snippet from our downloadable patient Brochure speakers: Dr. Herbert Loong from Kong. Patient in Asia, Middle East and Africa burn was us $ 118m here a. Provided is at least 10-minutes delayed and hosted by Barchart Solutions announced that its Chief Officer... Succeed Derek Bertocci who has retired after successfully ushering the company through its successful transition as a public company testing... Of the investor alerts you are subscribed to by visiting the ‘ ’! As hospital resources are currently over-burdened, scheduling Tissue biopsies can be difficult and…, Happy Vaisakhi - from of. Tissue biopsy: how Do They Compare COVID-19 pandemic - from all of us at Booth E04 on –. On New Interest oncologists, Dr. Shaheenah Dawood from U.A.E and delays of invasive tissue-based tests Asia, which… Guardant. You ready to make a difference in the laboratory patient Brochure has increased by 100.1 % is! New field of non-invasive diagnostics, on products that are transforming cancer care Charts, Nachrichten und Termine Guardant... By visiting the ‘ unsubscribe ’ section below conquering cancer with data we ’ re developing blood,...